Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-008722
Filing Date
2017-11-09
Accepted
2017-11-09 16:24:42
Documents
81
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q arlz-20170930x10q.htm 10-Q 1824661
2 EX-31.1 arlz-20170930ex311565edd.htm EX-31.1 15379
3 EX-31.2 arlz-20170930ex312e7ee88.htm EX-31.2 18969
4 EX-32.1 arlz-20170930ex3218c187c.htm EX-32.1 11018
5 EX-32.2 arlz-20170930ex3221a6d8f.htm EX-32.2 11081
  Complete submission text file 0001558370-17-008722.txt   7707715

Data Files

Seq Description Document Type Size
6 EX-101.INS arlz-20170930.xml EX-101.INS 1672404
7 EX-101.SCH arlz-20170930.xsd EX-101.SCH 59845
8 EX-101.CAL arlz-20170930_cal.xml EX-101.CAL 57534
9 EX-101.DEF arlz-20170930_def.xml EX-101.DEF 234264
10 EX-101.LAB arlz-20170930_lab.xml EX-101.LAB 532247
11 EX-101.PRE arlz-20170930_pre.xml EX-101.PRE 422730
Mailing Address 7100 WEST CREDIT AVENUE, SUITE 101 MISSISSAUGA A6 L5N 0E4
Business Address 7100 WEST CREDIT AVENUE, SUITE 101 MISSISSAUGA A6 L5N 0E4 905-876-1118
Aralez Pharmaceuticals Inc. (Filer) CIK: 0001660719 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37691 | Film No.: 171191189
SIC: 2834 Pharmaceutical Preparations